389 related articles for article (PubMed ID: 164219)
41. Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells.
Kishi Y; Ashikaga T; Watanabe R; Numano F
J Cardiovasc Pharmacol; 1994 Sep; 24(3):351-7. PubMed ID: 7528289
[TBL] [Abstract][Full Text] [Related]
42. Ca-2+/Mg-2+-dependent cyclic nucleotide phosphodiesterase and its activator protein.
Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
Adv Cyclic Nucleotide Res; 1975; 5():163-78. PubMed ID: 165664
[TBL] [Abstract][Full Text] [Related]
43. Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.
Pyne NJ; Cooper ME; Houslay MD
Biochem J; 1986 Mar; 234(2):325-34. PubMed ID: 3013156
[TBL] [Abstract][Full Text] [Related]
44. Excitation-secretion coupling in exocrine glands. Properties of cyclic AMP phosphodiesterase and adenylate cyclase from the submaxillary gland and pancreas.
Lemon MJ; Bhoola KD
Biochim Biophys Acta; 1975 Mar; 385(1):101-13. PubMed ID: 164921
[TBL] [Abstract][Full Text] [Related]
45. Properties of the cyclic GMP phosphodiesterase from rat lung. Inhibition by unsaturated fatty acids.
Coquil JF
Biochim Biophys Acta; 1983 Mar; 743(3):359-69. PubMed ID: 6299362
[TBL] [Abstract][Full Text] [Related]
46. The role of cyclic GMP in the regulation of cyclic AMP hydrolysis.
Terasaki WL; Appleman MM
Metabolism; 1975 Mar; 24(3):311-9. PubMed ID: 165353
[TBL] [Abstract][Full Text] [Related]
47. Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions.
Davis CW
Biochim Biophys Acta; 1984 Mar; 797(3):354-62. PubMed ID: 6320906
[TBL] [Abstract][Full Text] [Related]
48. Cyclic nucleotide phosphodiesterase in silkworm. Developmental change of cyclic AMP and cyclic GMP phosphodiesterases.
Morishima I
Biochim Biophys Acta; 1975 Sep; 403(1):106-12. PubMed ID: 240422
[TBL] [Abstract][Full Text] [Related]
49. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
50. Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parameters.
Liu YP; Schwartz HS
Biochim Biophys Acta; 1978 Sep; 526(1):186-93. PubMed ID: 210826
[TBL] [Abstract][Full Text] [Related]
51. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
Kuo JF; Shoji M; Brackett NL; Helfman DM
J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
[TBL] [Abstract][Full Text] [Related]
52. Cyclic nucleotide phosphodiesterase from a particulate fraction of rat brain. Evidence for an activator deficient form.
Lindl T; Chapman G
Biochem Biophys Res Commun; 1976 Aug; 71(4):1273-82. PubMed ID: 9937
[No Abstract] [Full Text] [Related]
53. Multiple cyclic nucleotide phosphodiesterases in rat kidney.
Gulyassy PF; Farrand JR; Gugler HD
Kidney Int; 1975 Nov; 8(5):284-91. PubMed ID: 537
[TBL] [Abstract][Full Text] [Related]
54. Rod outer segment phosphodiesterase: factors affecting the hydrolysis of cyclic-AMP and cyclic-GMP.
Chader G; Fletcher R; Johnson M; Bensinger R
Exp Eye Res; 1974 Jun; 18(6):509-15. PubMed ID: 4369151
[No Abstract] [Full Text] [Related]
55. Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes.
Thompson WJ; Ross CP; Pledger WJ; Strada SJ; Banner RL; Hersh EM
J Biol Chem; 1976 Aug; 251(16):4922-9. PubMed ID: 182685
[TBL] [Abstract][Full Text] [Related]
56. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs.
Davis CW; Kuo JF
Biochim Biophys Acta; 1976 Sep; 444(2):554-62. PubMed ID: 183829
[TBL] [Abstract][Full Text] [Related]
57. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
58. Cyclic nucleotide phosphodiesterase: high activity in a mammalian photoreceptor.
Pannbacker RG; Fleischman DE; Reed DW
Science; 1972 Feb; 175(4023):757-8. PubMed ID: 4333398
[TBL] [Abstract][Full Text] [Related]
59. Subcellular distribution of the enzymes related to the cellular action of vasopressin in renal medulla.
Barnes LD; Hui YS; Frohnert PP; Dousa TP
Endocrinology; 1975 Jan; 96(1):119-28. PubMed ID: 162875
[TBL] [Abstract][Full Text] [Related]
60. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.
Mullaney I; Clegg RA
Biochem J; 1984 May; 219(3):801-9. PubMed ID: 6331397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
